CARR EDWARD

Track

Insider profile

Performance

Overall performance
0.5
Performance over holding periods
0.5
30 days 90 days 120 days
Average return -39% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
CARR EDWARD's trades of Dianthus Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-13 2026-03-12
PlS Planned sale
26,172 -27.6%
377.55
US$24,960 		26,172 -27.6% 377.55 US$24,960
2026-03-13 2026-03-12
PlS Planned sale
7,129 -5.4%
414.13
US$2,937,460 		7,129 -5.4% 414.13 US$2,937,460
2026-03-13 2026-03-12
PlS Planned sale
94,278 -37.8%
389.06
US$4,522,774 		94,278 -37.8% 389.06 US$4,522,774
2026-03-13 2026-03-12
PlS Planned sale
23,465 -84.3%
81.75
US$1,918,264 		23,465 -84.3% 81.75 US$1,918,264
2026-03-13 2026-03-12
PlS Planned sale
15,852 -36.3%
80.71
US$1,279,415 		15,852 -36.3% 80.71 US$1,279,415
2026-03-12 2026-03-12
PrS Proposed sale
43,682
85.84
US$3,749,663 		43,682 85.84 US$3,749,663
2021-10-08 2021-10-08
PlS Planned sale
29,122 -6.8%
1.05
US$30,596 		29,122 -6.8% 1.05 US$30,596
2021-04-05 2021-04-05
PlS Planned sale
35,000 -15.5%
1.80
US$62,846 		35,000 -15.5% 1.80 US$62,846
2021-04-05 2021-04-01
PlS Planned sale
20,445 -8.3%
1.85
US$37,866 		20,445 -8.3% 1.85 US$37,866
2020-03-20 2020-03-19
S Sale
6,446 -32.2%
1.81
US$11,667 		6,446 -32.2% 1.81 US$11,667